Coronavirus disease 2019 (COVID-19) is a highly virulent infection that has caused a
pandemic since 2019. Early diagnosis of the disease has been recognized as one of the …

Background Infection of SARS-CoV-2 may cause acute respiratory syndrome. It has been
reported that SARS-CoV-2 nucleocapsid protein (N-protein) presents early in body fluids …

Background Although antivirals remain important for the treatment COVID-19, methods to
assess treatment efficacy are lacking. Here, we investigated the impact of remdesivir on viral …

Data on the performance of blood-based nucleocapsid antigen tests for diagnosing severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and infectious viral …

Gold nanoparticle-based point-of-care tests (POCT) are one of the most widely used
diagnostic tools for SARS-CoV-2 screening. However, the limitation of their insufficient …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid protein (N-
protein) increases early in body fluids during infection and has recently been identified as a …

The diagnostic of SARS-CoV-2 infection relies on reverse transcriptase polymerase chain
reactions (RT-PCRs) performed on nasopharyngeal (NP) swabs. Nevertheless, false …

To assess if SARS-CoV-2 (COVID-19) systemic disease can be determined by available
nucleoprotein assays, we compared the performance of three commercial SARS-CoV-2 …

Objectives Currently, no biomarker or scoring system could clearly identify patients at risk of
progression to a severe coronavirus disease (COVID)-19. Even in patients with known risk …

A fast and reliable method for the detection of molecular interactions in real‐time is
necessary for drug screening and control of infections or diseases. Therefore, this study …